Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

28.78B

Market cap28.78B

Price-Earnings ratio

35.17

Price-Earnings ratio35.17

Dividend yield

—

Dividend yield—

Average volume

2.07M

Average volume2.07M

High today

$193.66

High today$193.66

Low today

$187.92

Low today$187.92

Open price

$193.42

Open price$193.42

Volume

1.06M

Volume1.06M

52 Week high

$196.66

52 Week high$196.66

52 Week low

$88.00

52 Week low$88.00

Stock Snapshot

Illumina(ILMN) stock is priced at $190.20, giving the company a market capitalization of 28.78B. It carries a P/E multiple of 35.17.

During the trading session on 2026-07-11, Illumina(ILMN) shares reached a daily high of $193.66 and a low of $187.92. At a current price of $190.20, the stock is +1.2% higher than the low and still -1.8% under the high.

Trading activity shows a volume of 1.06M, compared to an average daily volume of 2.07M.

Over the past 52 weeks, Illumina(ILMN) stock has traded between a high of $196.66 and a low of $88.00.

ILMN News

MarketWatch 10h

Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch

...

TipRanks 2d

Illumina appoints Sullivan as CCO, Coletti as CLO

Illumina (ILMN) announced the appointment of Mike Sullivan as Chief Commercial Officer, CCO, effective July 20, 2026, and Julie Coletti as Chief Legal Officer,...

Simply Wall St 3d

Illumina Beat Expectations, Is The Stock Fully Priced?

Advertisement Illumina earnings jump start 2026 rally Illumina (ILMN) recently reported quarterly revenue of $1.09b, up 4.8% year on year and 1.8% above analy...

Analyst ratings

52%

of 23 ratings

Buy

52.2%

Hold

26.1%

Sell

21.7%

More ILMN News

TipRanks 5d

Illumina price target raised to $200 from $155 at Evercore ISI

Evercore ISI raised the firm’s price target on Illumina (ILMN) to $200 from $155 and keeps an Outperform rating on the shares. The firm’s Q2 preview for MedTech...

Simply Wall St 5d

Is Illumina Quietly Recasting Its Clinical Genomics Strategy With Eli Lilly’s R&D Chief on Board?

Illumina, Inc. recently expanded its Board from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., an independent director and Eli Lilly’s Chi...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.